Cargando…
Establishment of a Prediction Model for Overall Survival after Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer Using Radiomics Analysis
SIMPLE SUMMARY: Lung cancer remains the leading cause of cancer-related mortality worldwide. Although early-stage non-small cell lung cancer (NSCLC) is likely to be controlled with stereotactic body radiation therapy (SBRT), approximately 18% of patients lead to recurrence. The aim of this study was...
Autores principales: | Sawayanagi, Subaru, Yamashita, Hideomi, Nozawa, Yuki, Takenaka, Ryosuke, Miki, Yosuke, Morishima, Kosuke, Ueno, Hiroyuki, Ohta, Takeshi, Katano, Atsuto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405862/ https://www.ncbi.nlm.nih.gov/pubmed/36010853 http://dx.doi.org/10.3390/cancers14163859 |
Ejemplares similares
-
Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
por: Ogita, Mami, et al.
Publicado: (2021) -
Dosimetric Comparison Study Between Free Breathing and Breath Hold Techniques in Patients Treated by Liver-Directed Stereotactic Body Radiation Therapy
por: Katano, Atsuto, et al.
Publicado: (2023) -
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer
por: Sawayanagi, Subaru, et al.
Publicado: (2022) -
Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study
por: Yamashita, Hideomi, et al.
Publicado: (2022) -
Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)